Senseonics Holdings Surges 3.15% as Investors Eye New Diabetes Tech
Senseonics Holdings (SENS) edges up 3.15% after a steep drop, trading near its 52‑week high—investors weigh upcoming earnings, approvals, and its continuous glucose monitoring portfolio for next‑step momentum.
2 minutes to read